GNTA logo
GNTA NASDAQ IT

Genenta Science S.p.A. - American Depositary Shares

Healthcare · Biotechnology Website · IPO Dec 2021
$0.71
▲ +$0.01 (+1.87%)
Vol 36K
4
Quality Score
fail
Mkt Cap
$28.5M
ROE
-70.7%
D/E
62.37
Beta
0.65
52W
$1–$10

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -70.7% -60.8% -60.8% -60.8% -70.7% -70.7%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 62.37 0.00 0.00 0.00 62.37 62.37
Current Ratio 13.20 6.89 6.89 6.89 13.20 13.20

Key Ratios

ROA (TTM)
-47.8%
P/B
5.4
EPS (TTM)
$-0.47
CF/Share
$-0.78
52W High
$10.00
52W Low
$1.28
$1.28 52-Week Range $10.00

How does GNTA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

GNTA AAPG ABEO ABOS ABP

GNTA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
5.4
▲ 120% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

GNTA profitability vs Biotechnology peers

ROE
-70.7%
▼ 5% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-47.8%
▼ 2% below peers (-46.7%)
vs Peers
vs Industry
In line

GNTA financial health vs Biotechnology peers

D/E ratio
62.4
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
13.2
▲ 197% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.7
▼ 33% below peers (1.0)
vs Peers
vs Industry
More volatile

GNTA fundamentals radar

GNTA Peer median Industry

GNTA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

GNTA vs peers: key metrics

Latest News

No related news yet